TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/2/24 19:13 | 9/30/24 | BGNE | Beigene, Ltd. | Health | Drug | Pharmaceutical Preparations | Lee Chan Henry | E9 | O | SVP,GC | S | -285 | 237.10 | 0 | -1 | -1 | 237 | D | |||||||||||||||
8/1/24 17:06 | 7/30/24 | BGNE | Beigene, Ltd. | Health | Drug | Pharmaceutical Preparations | Lee Chan Henry | E9 | O | SVP,GC | S | -134 | 160.57 | 0 | -1 | 0 | 253 | D | |||||||||||||||
6/20/24 17:24 | 6/17/24 | BGNE | Beigene, Ltd. | Health | Drug | Pharmaceutical Preparations | Lee Chan Henry | E9 | O | SVP,GC | S | -70 | 159.35 | 0 | 0 | 0 | 264 | D | |||||||||||||||
8/2/23 17:10 | 7/31/23 | BGNE | Beigene, Ltd. | Health | Drug | Pharmaceutical Preparations | Lee Chan Henry | E9 | O | SVP,GC | S | -171 | 216.26 | 0 | -1 | 0 | 171 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |